Atalanta Therapeutics Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
BOSTON, May 22, 2024 BUSINESS WIRE Atalanta Therapeutics , a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the expansion of its executive team with the appointments of Serena Hung, M.D., as chief medical officer, and Jeffrey Young as chief financial officer. Dr. Hung is a board-certified neurologist who has held leadership roles at prominent CNS drug development companies, and Mr. Young is a seasoned financial executive with capital markets expertise and with over two decades of experience in life sciences. "We are thrilled to welcome Jeffrey and Serena to Atalanta's executive team as we prepare for our next phase of growth in building the leading CNS RNAi company," said Alicia Secor, Atalanta's president and chief executive officer. "Atalanta's discovery efforts utilize our best-in-class di-siRNA platform and have generated a robust portfolio of 14 current programs across our wholly-owned and partnered pipeline
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA EditingGlobeNewswire
- Wave Life Sciences to Present at 2024 Jefferies Global Healthcare ConferenceGlobeNewswire
- Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $11.00 price target on the stock.MarketBeat
- Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 5/9/24 - Miss
WVE
Sec Filings
- 5/10/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/29/24 - Form 10-K/A
- WVE's page on the SEC website